InvestorsHub Logo
Followers 62
Posts 2098
Boards Moderated 0
Alias Born 05/09/2020

Re: A deleted message

Thursday, 05/12/2022 3:26:20 PM

Thursday, May 12, 2022 3:26:20 PM

Post# of 233578
Isn't this the study where Veru's placebo group had a ~42% mortality whereas all the other COVID therapeutics were in the ~25% range?

Talk about screwing with the numbers.....

Found it....

Veru's study:

Placebo group (n=52) had a 45% mortality rate compared to the sabizabulin-treated group (n=98) which had a 20% mortality rate.


https://www.biospace.com/article/releases/veru-s-novel-covid-19-drug-candidate-reduces-deaths-by-55-percent-in-hospitalized-patients-in-interim-analysis-of-phase-3-study-independent-data-monitoring-committee-halts-study-early-for-overwhelming-efficacy/

Meta-analysis of COVID studies:

We identified nine studies [9–17] with 7766 subjects, including three additional studies [13, 15, 17] following publication of the guidelines. Overall, mortality in the treatment groups was 714 (25.6%) out of 2793, and in the control groups was 1365 (27.4%) out of 4973.


https://err.ersjournals.com/content/30/162/210171

Not something to hang one's hat on for "outstanding" results....
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News